TABLE 2.
Reference | Patients population | Number of patients/controls | Assessment method | Main results | ||
---|---|---|---|---|---|---|
Muscle strength | Muscle mass/quality | Physical performance | ||||
Kakihana et al., 2017, J Vasc Surg |
PAD | 16/10 | ‐ | ‐ | 7‐m walkway embedded with a force plate test | PAD was associated with slower walk at self‐selected walking speed (88.32 ± 15.15 cm/s for PAD patients vs. 126.04 ± 16.31 cm/s for controls, P < 0.001) and at fast walking speed (119.90 ± 21.07 cm/s vs. 162.01 ± 21.47 cm/s for controls, P < 0.001); lower cadence at self‐selected walking speed (109.92 ± 12.17 step/min vs. 118.38 ± 7.28 steps/min, P < 0.001) and at fast walking speed (121.29 ± 11.39 steps/min vs. 135.11 ± 9.47 step/min, P < 0.001); and reduced peak hip flexor generation power at self‐selected walking speed (0.50 ± 0.18 W/kg vs. 1.00 ± 0.22 W/kg, P < 0.001) and at fast walking speed (0.78 ± 0.27 W/kg vs. 1.40 ± 0.39 W/kg, P < 0.001) |
Schieber et al., 2017, J Vasc Surg |
PAD | 94/16 | Maximal isometric plantar flexion contractions of 10 s | ‐ | ‐ | PAD patients exhibited strength deficits, with impaired peak torque values (69.1 ± 28.7 N.m for claudicating patients vs. 98.2 ± 27.6 N.m for controls, P < 0.01) |
Dziubek et al., 2015, Maturitas |
CLI | 85/50 | Force‐velocity parameters (peak torque, total work, average power) of the lower limb | ‐ | 6‐min walk test | PAD was associated with lower 6‐min walk distance (349.77 ± 65.08 m for PAD patients vs. 515.86 ± 96.39 for controls, P < 0.0001), lower mean walk speed (3.49 ± 0.65 km/h vs. 5.15 ± 0.96 km/h for controls, P < 0.01), and significantly lower values of force‐velocity parameters (including peak torque, total work and average power of the knee joint) compared with the control group (P < 0.005) |
Parmenter et al., 2013, J Vasc Surg |
PAD | 22/− | Maximum strength/endurance testing (hip extensors, hip abductors, quadriceps, hamstrings, plantar flexors, pectoral, upper back muscles) | ‐ | 6‐min walk test | Greater severity of PAD was associated with reduced bilateral hip extensor strength (r = 0.54, P = 0.007), whole body strength (r = 0.32, P = 0.05), shorter distance to first stop during the 6‐min walk test (r = 0.38, P = 0.05) and poorer single leg balance (r = 0.44, P = 0.03) (using univariate and stepwise multiple regression models) |
Câmara et al., 2012, Ann Vasc Surg |
PAD | 20/9 | Plantar flexion/dorsiflexion movements, knee extension/flexion movements | ‐ | Plantar flexion/dorsiflexion movements, knee extension/flexion movements |
PAD patients presented lower muscle strength in dorsiflexion (0.20 ± 0.10 N/m/kg for PAD patients vs. 0.29 ± 0.10 N/m/kg for controls, P < 0.01), plantar flexion (0.36 ± 0.20 N/m/kg vs. 0.53 ± 0.20 N/m/kg, P < 0.01) and knee flexion movements (0.50 ± 0.30 N/m/kg vs. 0.62 ± 0.10, P = 0.04). Also, PAD was associated with lower muscle endurance in dorsiflexion (8.0 ± 3.5 N/m/kg vs. 9.9 ± 6.6 N/m/kg, P = 0.01) and plantar flexion movements (20.0 ± 9.0 N/m/kg vs. 25.7 ± 10.7 N/m/kg, P = 0.02) |
Wurdeman et al., 2012, Gait Posture |
PAD | 30/32 | Joint moments and powers at early, mid and late stance (hip and knee and ankle joints) | ‐ | ‐ | PAD was associated with reduced peak hip power absorption in midstance (−0.788 ± 0.25 W/kg for PAD patients vs.−0.950 ± 0.27 W/kg for controls, P = 0.017), reduced peak knee power absorption in late stance (−0.729 ± 0.21 W/kg vs.−0.899 ± 0.33 W/kg for controls, P = 0.02), and reduced peak ankle power generation in late stance (2.677 ± 0.45 W/kg vs. 2.998 ± 0.60 W/kg, P = 0.021) |
Koutakis et al., 2010, J Vasc Surg |
PAD | 20/16 | Joint torques and powers at early, mid and late stance (hip, knee and ankle joints) | ‐ | Ambulation on a walkway |
PAD patients presented significantly reduced hip power generation in late stance (0.569 ± 0.18 W/kg for claudicating patients vs. 0.706 ± 0.24 W/kg for controls, P = 0.03), knee power absorption in late stance (−0.580 ± 0.25 W/kg vs. −0.882 ± 0.32 W/kg, P = 0.0015), and ankle power generation in late stance (2.178 ± 0.51 W/kg vs. 2.957 ± 0.69 W/kg, P = 0.0001) Also, PAD was associated with reduced gait velocity (1.09 ± 0.13 m/s for claudicating patients vs. 1.28 ± 0.13 m/s for controls, P = 0.0007) and stride length (1.27 ± 0.11 m vs. 1.47 ± 0.11 m for controls, P < 0.001) |
Koutakis et al., 2010, J Vasc Surg |
PAD | 20/10 | Joint torques and powers at early, mid and late stance (hip, knee and ankle joints) | ‐ | ‐ | PAD was associated with reduced knee power generation in early stance (0.26 ± 0.31 W/kg for claudicating patients vs. 0.62 ± 0.25 W/kg for controls, P < 0.05) and ankle power generation in late stance (2.05 ± 0.59 W/kg vs. 4.00 ± 0.88 W/kg for controls, P < 0.05) |
Herman et al., 2009, J Am Geriatr Soc |
PAD | 374/− |
Hip extension/flexion, knee extension/flexion strength Walking over a force platform |
‐ |
7‐m walking speed test 6‐min walk test Short physical performance battery |
In women with PAD, weaker baseline hip and knee flexion strength were associated with faster average annual decline in usual‐paced 4‐m walking velocity (P trend < 0.001 and P trend = 0.02 respectively) and in short physical performance battery test (P trend = 0.019 and P trend = 0.01, respectively) |
McDermott et al., 2008, J Am Geriatr Soc |
PAD | 424/271 |
Isometric knee extension/plantar flexion strength Handgrip strength Knee extension power |
‐ |
6‐min walk test 4‐m walking velocity test |
Lower arterial brachial index values were associated with lower plantar flexion strength (P trend = 0.04) and lower knee extension power (P trend < 0.001) |
Kuo et al., 2008, J Gerontol A Biol Sci Med Sci |
PAD | 206/1592 | Isokinetic dynamometer | ‐ | 20‐ft timed walk test | PAD associated with weak leg force, low gait speed and functional dependence (based on multiple logistic regression analyses) |